EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation

Aikaterini Gatsiou, Simon Tual-Chalot, Matteo Napoli, Almudena Ortega-Gomez, Tommy Regen, Rachit Badolia, Valeriana Cesarini, Claudia Garcia-Gonzalez, Raphael Chevre, Giorgia Ciliberti, Carlos Silvestre-Roig, Maurizio Martini und 26 weitere

Immunity · 2023-05 · 56 (5) · 979-997.e11

DOI: 10.1016/j.immuni.2023.03.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2023-05. Verfasst von Aikaterini Gatsiou und 37 weiteren Autor:innen. Beteiligte Einrichtung: Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; RNA Metabolis…. Hauptthemen laut MEDLINE: RNA, Interleukin-6. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Biotechnology and Biological Sciences Research Council, Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune cell trafficking constitutes a fundamental component of immunological response to tissue injury, but the contribution of intrinsic RNA nucleotide modifications to this response remains elusive. We report that RNA editor ADAR2 exerts a tissue- and stress-specific regulation of endothelial responses to interleukin-6 (IL-6), which tightly controls leukocyte trafficking in IL-6-inflamed and ischemic tissues. Genetic ablation of ADAR2 from vascular endothelial cells diminished myeloid cell rolling and adhesion on vascular walls and reduced immune cell infiltration within ischemic tissues. ADAR2 was required in the endothelium for the expression of the IL-6 receptor subunit, IL-6 signal transducer (IL6ST; gp130), and subsequently, for IL-6 trans-signaling responses. ADAR2-induced adenosine-to-inosine RNA editing suppressed the Drosha-dependent primary microRNA processing, thereby overwriting the default endothelial transcriptional program to safeguard gp130 expression. This work demonstrates a role for ADAR2 epitranscriptional activity as a checkpoint in IL-6 trans-signaling and immune cell trafficking to sites of tissue injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNAInterleukin-6Endothelial CellsCytokine Receptor gp130EndotheliumAdenosine Deaminase

Stichwörter der Autor:innen

ADAR2IL-6RNA editingRNA modificationsendothelial cellsepitranscriptomegene expressionimmune cell traffickingischemiamicroRNAs

Substanzen

RNAInterleukin-6Cytokine Receptor gp130Adenosine Deaminase

Autor:innen und Institutionen

  • Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; RNA Metabolism and Vascular Inflammation Laboratory, Institute of Cardiovascular Re…
  • Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Institute for Cardiovascular Physiology and Pathophysiology, Walter Brendel Center for Experimental Medicine Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany.
  • Institute for Cardiovascular Prevention (IPEK), LMU Munich Hospital, Munich, Germany.
  • Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.
  • Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI), University of Utah School of Medicine, Salt Lake City, UT, USA.

Förderung

  • NHLBI NIH HHS
  • Biotechnology and Biological Sciences Research Council
  • Associazione Italiana per la Ricerca sul Cancro
  • Horizon 2020 Framework Programme
  • Newcastle University
  • European Research Council
  • Universität Heidelberg
  • Albert Einstein College of Medicine, Yeshiva University

Zitieren

APA

Gatsiou, A., Tual-Chalot, S., Napoli, M., Ortega-Gomez, A., Regen, T., Badolia, R., Cesarini, V., Garcia-Gonzalez, C., Chevre, R., Ciliberti, G., Silvestre-Roig, C., Martini, M., Hoffmann, J., Hamouche, R., Visker, J. R., Diakos, N., Wietelmann, A., Silvestris, D. A., Georgiopoulos, G., …, & Stellos, K. (2023). The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation. Immunity, 56(5), 979-997.e11. https://doi.org/10.1016/j.immuni.2023.03.021

Vancouver

Gatsiou A, Tual-Chalot S, Napoli M, Ortega-Gomez A, Regen T, Badolia R, et al. The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation. Immunity. 2023;56(5):979-997.e11. doi:10.1016/j.immuni.2023.03.021

BibTeX
@article{Gatsiou2023,
  author = {Gatsiou, Aikaterini and Tual-Chalot, Simon and Napoli, Matteo and Ortega-Gomez, Almudena and Regen, Tommy and Badolia, Rachit and Cesarini, Valeriana and Garcia-Gonzalez, Claudia and Chevre, Raphael and Ciliberti, Giorgia and Silvestre-Roig, Carlos and Martini, Maurizio and Hoffmann, Jedrzej and Hamouche, Rana and Visker, Joseph R and Diakos, Nikolaos and Wietelmann, Astrid and Silvestris, Domenico Alessandro and Georgiopoulos, Georgios and Moshfegh, Ali and Schneider, Andre and Chen, Wei and Guenther, Stefan and Backs, Johannes and Kwak, Shin and Selzman, Craig H and Stamatelopoulos, Kimon and Rose-John, Stefan and Trautwein, Christian and Spyridopoulos, Ioakim and Braun, Thomas and Waisman, Ari and Gallo, Angela and Drakos, Stavros G and Dimmeler, Stefanie and Sperandio, Markus and Soehnlein, Oliver and Stellos, Konstantinos},
  title = {The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation},
  journal = {Immunity},
  year = {2023},
  volume = {56},
  number = {5},
  pages = {979--997.e11},
  doi = {10.1016/j.immuni.2023.03.021}
}
Kostenlos starten →